enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tezepelumab - Wikipedia

   en.wikipedia.org/wiki/Tezepelumab

   Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5] [7] [8] [9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.

3. First new asthma attack treatment in 50 years - AOL

   www.aol.com/news/first-asthma-attack-treatment...

   Dr Samantha Walker, from the charity Asthma + Lung UK, said the results were "great news". "But it’s appalling that this is the first new treatment for those suffering from asthma and COPD ...

4. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...

5. If You're Living With Asthma, Here's Every Single Treatment ...

   www.aol.com/youre-living-asthma-heres-every...

   The good news? Treatments for the chronic condition are highly effective. ... Several asthma medications are available in oral pill, chewable or tablet form, as well. Corticosteroids, for instance ...

6. FDA approves medication used to treat asthma for use in ... - AOL

   www.aol.com/news/fda-approves-medication-used...

   The US Food and Drug Administration on Friday approved a medication called Xolair to help lessen the severity of an accidental allergic reaction in people who are allergic to multiple foods.

7. Long-acting beta-adrenoceptor agonist - Wikipedia

   en.wikipedia.org/wiki/Long-acting_beta...

   This second medication in this combination is the synthetic inhaled corticosteroid fluticasone furoate. This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta.